{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-337069","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2026-08-06T14:08:06+00:00","discovered_at":"2026-08-06T14:09:00.446814+00:00","generated_at":"2026-08-06T14:09:06.957394+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Whitehawk Therapeutics Q2 net loss narrows to $16.6M; cash $190M, runway into 2H 2028","bullets":["Net loss of $16.6M for Q2 2026, compared to $52.6M in Q2 2025; R&D expenses fell to $12.9M from $48.8M.","Cash, equivalents and short-term investments $190.0M at June 30, 2026, up from $145.7M at Dec 31, 2025.","Completed $87.5M private placement equity financing in May 2026 with existing and new investors.","Phase 1 trials for HWK-007 and HWK-016 continue enrolling; initial results expected in 1H 2027.","Entered option agreement with Hangzhou DAC for CPT113 linker-payload and collaboration with Biocytogen for bispecific ADCs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-337069","json":"https://secwatch.observer/filing/0001193125-26-337069.json","markdown":"https://secwatch.observer/filing/0001193125-26-337069.md","text":"https://secwatch.observer/filing/0001193125-26-337069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312526337069/0001193125-26-337069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312526337069/whwk-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T14:09:06.957394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}